GSK, the British pharmaceutical company, is the latest to join the club. The company has pledged to invest $30 billion in establishing manufacturing, research, and supply chain facilities in the US over the next 5 years. The announcement came on Sept. 17, during Trump’s recent 3-day visit to the UK.
add a skeleton here at some point
4 days ago